Quadient S.A. : Close to an important technical resistance levels
Entry price | Target | Stop-loss | Potential |
---|
€18.13 |
€20.45 |
€16.4 |
+12.8% |
---|
Shares in Quadient S.A. are approaching an important resistance level. The stock's technical chart suggests that this pivot level will be broken.
Summary● In a short-term perspective, the company has interesting fundamentals.
Strengths● The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
● The stock is in a well-established, long-term rising trend above the technical support level at 12.97 EUR
Weaknesses● The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
● The company is in debt and has limited leeway for investment
● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.